ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
US Tech 100
18,387.60
0.38%
Dow Jones
38,852.86
-0.55%
Brent Oil
84.135
-0.23%
Bitcoin
68,697.94
0.60%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Bio Techne Corporation (TECH) Quote

Bio Techne Corporation

Bio Techne Corporation (TECH)

TechFinancials Inc
Global X Management AUS Ltd
Evolve Fangma Index ETF
79.39
-1.40
(-1.73%)
Closed May 28 4:00PM
Delayed by 15 minutes
80.00
0.61
(0.77%)
After Hours: 7:03PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
80.00
Bid
77.60
Ask
81.15
Volume
704,175
79.04 Day's Range 80.93
51.79 52 Week Range 89.91
Market Cap
12.479B
Previous Close
80.79
Open
80.80
Last Trade
10
@
78.71
Last Trade Time
Financial Volume
$ 55,955,596
VWAP
79.4626
Average Volume (3m)
1,129,837
Shares Outstanding
157,191,685
Dividend Yield
0.40%
PE Ratio
43.75
Earnings Per Share (EPS)
1.81
Revenue
1.14B
Net Profit
285.26M

About Bio Techne Corporation

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.bio-techne.com
Headquarters
Minneapolis, Minnesota, USA
Founded
1970
Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TECH. The last closing price for Bio Techne was $80.79. Over the last year, Bio Techne shares have traded in a share price range of $ 51.79 to $ 89.91.

Bio Techne currently has 157,191,685 shares outstanding. The market capitalization of Bio Techne is $12.48 billion. Bio Techne has a price to earnings ratio (PE ratio) of 43.75.

TECH Latest News

More News

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE PR Newswire MINNEAPOLIS, May 23, 2024 MINNEAPOLIS, May 23, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

May 23 2024
PR Newswire (US)

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY PR Newswire MINNEAPOLIS, May 22, 2024 MINNEAPOLIS...

May 22 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

May 16 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

May 14 2024
Edgar (US Regulatory)

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 PR Newswire MINNEAPOLIS, May 8, 2024 MINNEAPOLIS, May 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...

May 08 2024
PR Newswire (US)

BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)

BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) PR Newswire MINNEAPOLIS, May 7, 2024 MINNEAPOLIS, May 7, 2024 /PRNewswire/...

May 07 2024
PR Newswire (US)

BIO-TECHNE DECLARES DIVIDEND

BIO-TECHNE DECLARES DIVIDEND PR Newswire MINNEAPOLIS, May 1, 2024 MINNEAPOLIS, May 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided...

May 01 2024
PR Newswire (US)

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS PR Newswire MINNEAPOLIS, May 1, 2024 MINNEAPOLIS, May 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its...

May 01 2024
PR Newswire (US)

BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS

BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS PR Newswire MINNEAPOLIS, April 30, 2024 MINNEAPOLIS, April 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...

April 30 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.42-2.936180538782.4283.9679.0469556381.80045218CS
415.9624.921923797664.0485.5763.16123589578.39706335CS
125.647.5847229693474.3685.5761.16112983772.43488568CS
2617.7828.576020572262.2285.5761.16110799371.66816058CS
52-3.8-4.5346062052583.889.9151.79104250971.71820028CS
156-22.7275-22.1240660972102.7275135.962551.7964313979.97240809CS
26030.54561.763219088149.455135.962538.792545940277.88409635CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STSSSharps Technology Inc
$ 0.5289
(146.80%)
302.08M
AWINAERWINS Technologies Inc
$ 8.99
(139.10%)
5.41M
INSMInsmed Inc
$ 48.107
(118.67%)
33.42M
GVVisionary Holdings Inc
$ 0.38
(90.00%)
10.33M
SOBRSOBR Safe Inc
$ 0.41
(82.22%)
130.83M
APDNApplied DNA Sciences Inc
$ 0.580601
(-70.82%)
9.45M
LUCYInnovative Eyewear Inc
$ 0.40
(-59.31%)
84.98M
MRAIMarpai Inc
$ 0.90
(-53.61%)
803.83k
TOIIWOncology Institute Inc
$ 0.021
(-52.60%)
293.22k
SHOTWSafety Shot Inc
$ 0.21
(-36.07%)
24.26k
PEGYPineapple Energy Inc
$ 0.2595
(45.70%)
676.58M
GWAVGreenwave Technology Solutions Inc
$ 0.0782
(-7.89%)
306.52M
STSSSharps Technology Inc
$ 0.5289
(146.80%)
302.07M
CRKNCrown Electrokinetics Corporation
$ 0.1073
(6.24%)
232.53M
OBLGOblong Inc
$ 0.21
(19.32%)
146.15M

TECH Discussion

View Posts
LordTurkeyBaster LordTurkeyBaster 2 years ago
Top Meme Stock Mentions Money to Move 01/03/2022

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 years ago
Top Meme Stock Mentions Money to Move 10/15/2021

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 years ago
Top Meme Stock Mentions Money to Move 10/14/2021

$TECH: $1B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
TREND1 TREND1 9 years ago
NO REASON.
👍️0
getarealjob getarealjob 9 years ago
No worries, just read a blurb on a new diet drug that sounds pretty promising from these guys. Fexaramine, from these guys, looking at clinicals in 2-3 years.

Is there a reason you're no longer following it or just got tired and needed more time with others?
👍️0
TREND1 TREND1 9 years ago
NO longer follow TECH.
SORRY
👍️0
getarealjob getarealjob 9 years ago
Hey Trend, saw you over on AAL. This guy just popped up on my radar, obviously nothing going on in the board. What are your thoughts on this, if you have any beyond your charts? Not sure if you're on this one or not.
👍️0
TREND1 TREND1 9 years ago
TECH D
👍️0

Your Recent History

NASDAQ
TECH
Bio Techne
POLO
WSTREETBABYUSDT
WALL STREET BABY
EU
0403T
0403T
BIT
P1Y565
NLBNPIT1Y565 20991231 70...
COIN
MXCBTC
MXCToken
BIT
UC1C51
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved